Table 5.
In vivo studies on Wistar rats.
Classification | Compound/Extract | Source | Experimental Model | Dose; Duration | Efficacy | Mechanism | Reference |
---|---|---|---|---|---|---|---|
Flavone | Baiclin | Scutellaria baicalensis | 1) NCI–H295R 2)Wistar rats |
1) 0.1, 1, 12.5, 25, 50, 100, 200 mmol/L; 24, 48, 72 h 2)20 mg/kg/day; 4 weeks |
Improvement of hyperandrogenism in PCOS | ↓HSD3B2, GATA1 | [48] |
Alkaloid | Berberine | Coptis sp. and Berberis sp | Wistar rats | 100, 200 mg/kg/day; | Improvement of ovulation and endometrial receptivity in PCOS | ↑Cyp19a1 ↓ 3, LPAR3 |
[49] |
Tannin | Hydrolyzable tannin | Wistar rats | 1.5, 2%/kg/body weight; 42 days | Improvement of PCOS | ↑IgM | [50] | |
Isoflavone | Nanocurcumin | Curcuma longa | Wistar rats | 100, 200 mg/kg; 15 days | Reduction of PCOS risk | ↑miR-223-3p, GSH, CAT, β-cell ↓LC3II, p62, IL-6, NF-κB |
[51] |
Flavonol | Quercetin | Plants polyphenolic flavonoid | Wistar rats | 100 mg/kg BW/day; 15 days | Alleviation of polycystic ovary | ↑SOD, CAT, GST, ATPase, Ca2+ ATPase, H+ ATPase, Bcl2, E-Cadherin ↓MDA, VEGF, TNF-, mRNA AR gene, Bax |
[52] |
Terpene | Thymoquinone | Nigella sativa L. | Wister rats | 0.75 mg/100 mL olive oil/rat, or 15 mg/kg body weight; 16 h, 40 h | Improvement of PCOS | ↑Cyp19a1, Sqstm1, P62/SQSTM1 ↓AR, Beclin1, Atg5, Map-LC3- I, Map-LC3- II, P65 |
[53] |
Vitamin | Vitamin C | Tropical fruits | Wistar rats | 150 mg/kg BW/day; 15 days | Protection against polycystic ovary | ↑CAT, ATPase enzymes activity, Bcl-2, E-cadherin ↓MDA, TNF-, VEGF, AR, Bax |
[54] |
Plant | Bee pollen | Anthophila | Wistar rats | 50,100,200 mg/kg/day; 21 days | Therapeutic effect on PCOS | ↑Bax, Caspase-3, Sirt-1 ↓Bcl-2 |
[55] |
Plant | Caesalpenia bonducella ethanol extract | Guilandina bonduc | Wistar rats | 200, 400 mg/kg; 28 days | Improvement of PCOS | ↑SOD CAT, GST, ↓GPx, GR |
[56] |
Plant | Chamomile | Matricaria chamomilla L. | Wistar rats | 75 mg/kg/day; 30 days | Improvement of PCOS | ↑GPx, CAT ↓caspase-3, MDA, |
[57] |
Plant | Fennel seed extract | Foeniculum vulgare | Wistar rats | 150 mg/kg/day; 15 days | Regulation of the hormonal and biochemical changes of PCOS | ↑FSH, HDL ↓Insulin, LH, FBS, testosterone, total triglycerides, total cholesterol |
[58] |
Plant | F. religiosa 10 % fresh leaf extract | Ficus religiosa | Wistar rats | 1.0 mL/kg/day; 30 days (oral, spray) | Alleviation of PCOS | ↑GSH, GPx, SOD, CAT, Cyp19a1, PPAR- ↓3 -HSD, 17 -HSD, HmG-CoA reductase, TC |
[59] |
Plant | F. religiosa aqueous dry leaf extract | Ficus religiosa | Wistar rats | 100, 300 mg/kg/day; 30 days | Alleviation of PCOS | ↑GSH, GPx, SOD, CAT, Cyp19a1, PPAR- ↓3 -HSD, 17 -HSD, HmG-CoA reductase |
[59] |
Plant | Ginger extract | Zingiber officinale Roscoe | Wistar rats | 175,350 mg/kg/day; 88 days | Improvement of PCOS | ↑LH, estrogen; ↓progesterone, FSH |
[60] |
Plant | Gymnema sylvestre ethanol extract | Gymnema sylvestre | Wistar rats | 100 mg/kg/day; 28 days | Inhibition in insulin resistance and androgen production | ↑Luteinizing hormone, testosterone, estrogen; ↓follicle-stimulating hormone, progesterone |
[61] |
Plant | Hedge woundwort |
Stachys sylvatica L. |
Wistar rats | 100, 250, 500 mg/kg; 10 days |
Improved obesity. Reduced cystic follicles. |
Improvement of folliculogenesis and regulation of gonadotropins synthesis | [62] |
Plant | Majoram extract | Origanum majorana | Wistar rats | 20 mg/kg/day; 24 days | Beneficial ameliorative effects against PCOS | ↑SOD, GPx ↓IL-6 |
[63] |
Plant | Pergularia daemia ethanol extract | Pergularia daemia | Wistar rats | 300 mg/kg/day; 28 days | Improvement of ovulation and menstrual irregularity | ↓follicle-stimulating hormone, progesterone | [61] |
Plant | Chitosan-engaged tripolyphosphate ions and concurrent loading of the biomolecules of the ethanolic extract of fennel seed | Foeniculum vulgare | Wistar rats | 50 mg/kg/day; 15 days | Regulation of the hormonal and biochemical changes of PCOS | ↑FSH, HDL ↓Insulin, LH, FBS, |
[58] |
Decoction | Combination of Gymnema sylvestre, Pergularia daemia ethanol extract | Gymnema sylvestre, Pergularia daemia | Wistar rats | 400 mg/kg/day; 28 days | Synergistic effects against PCOS | ↑Luteinizing hormone, testosterone, estrogen | [61] |
Plant | Actaea racemosa and Vitamin C | Cimicifuga racemosa | Wistar rats | AR extract 7.14 mg/kg, vitamin C 500 mg/kg; 28days | Alleviation of PCOS without hepatic adverse effect | ↑GSH, Ki-67, Cyp19a1 ↓MDA |
[64] |
Decoction | Chia seed, Walnut | Salvia hispenica, Prunus dulcis | Wister rats | 40 g, 40 g, 20 g & 20 g/day; 15 days | Regulation of the hormone level | ↓body and ovarian weights | [65] |
Decoction | Fennel essential oil, flaxseed oil | Foeniculum vulgare, Linum usitatissimum | Wistar rats | (1)100 mg/kg (2) 429 mg/kg (3) combination 100 mg/kg & 429 mg/kg; 50 days |
Improvement of the follicle conditions of PCOS | ↓cystic follicles | [66] |
Decoction | Hochu-ekki-to | Wistar rats | 500 mg/kg/day; 7 days | Improvement of ovarian reproductive and immune functions. | ↑ER-, ER-, IL-2, IL-4, IFN-, ↓AR, NGFR, GR, MAP2K-2, Hsp 90 |
[67] | |
Decoction | Kañcanāra Guggulu | Bauhinia variegate L., Terminalia chebula Retz., Terminalia bellerica, Emblica officinalis, Zingiber officinale, Pipernigrum, Piper longum Linn., Crataeva nurvala, Elettaria cardamomum, Cinnamomum zeylanicum, Commiphora mukul | Wistar rats | 100 mg/kg/day; 28 days | Regularization of the estrous cycle | ↓body weight, lipid profile, Blood glucose | [68] |
Decoction | Niśāmalakī | Curcuma longa, Emblica officinalis | Wistar rats | 0.9 g/kg/day; 28 days | Correction of changes induced by PCOS | ↓body weight, lipid profile, Blood glucose | [68] |
Decoction | Sahoyao-gancao decoction | Radix Paeoniae Alba., Glycyrrhizae uralensis | rats | 12.5, 25,50 g/kg; 14 days | Treatment of PCOS | ↑IκB. ↓TNF-α, IL-1β, IL-6, and IL-18, P– NF-κB, p- NF-κB p65 |
[69] |
Decoction | Unkeito | Paeonia lactiflora, Cinnamomum cassia | rats | Improvement of the follicle conditions of PCOS | ↑gonadotropins | [70] |
PCOS, polycystic ovary syndrome; Bax, bcl-2-associated X protein; CYP19a1, cytochrome P450, family 19, subfamily a, polypeptide 1; LPAR3, lysophosphatidic acid receptor 3; GPx, glutathione peroxidase; CAT, catalase; MDA, malondialdehyde; miR, microRNAs; GSH, glutathione; LC3II, light chain 3 II; p62, Sequestosome 1; IL-6, interleukin 6; NF-κB, nuclear factor-kappa B; SOD, superoxide dismutase; GST, glutathione-S-transferase; MDA, malondialdehyde; VEGF, vascular endothelial growth factor; TNF-α, Tumor osis factor-α; mRNA AR gene, mRNA androgen receptor gene; Cyp19a1, Cytochrome P450 Family 19 Subfamily A Member 1; HSD3B2, Hydroxy-Delta-5-Steroid Dehydrogenase, 3 Beta- And Steroid Delta-Isomerase 2; GATA1, GATA Binding Protein 1; GSH, reduced glutathione; GPx, glutathione peroxidase; PPAR-, peroxisome proliferator-activated receptor-; 3 -HSD, 3 -Hydroxysteroid dehydrogenase; 17 -HSD, 17 - Hydroxysteroid dehydrogenase; GR, glucocorticoid receptor; Sqstm1, Sequestosome 1; AR, androgen receptor; Beclin1, Atg5, Autophagy Related 5; Map-LC3- I, Microtubule-associated proteins 1A/1B light chain 3B; ER-, estrogen receptor-; ER-, estrogen receptor ; IL-2, interleukin-2; IL-4, interleukin 4; IFN-, interferon-; NGFR, nerve growth factor receptor; MAP2K-2, mitogen-activated protein kinase kinase 2; Hsp 90, heat shock protein 90; IκB, IkappaB kinase; IL-1β, interleukin-1β; IL-18, Interleukin-18; ↑, up-regulation; ↓, down-regulation.